Journal of neuro-oncology
Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of cytoreductive surgery in the management of progressive glioblastoma in adults
Abstract
In patients with previously diagnosed glioblastoma who are suspected of experiencing progression, does repeat cytoreductive surgery improve progression free survival or overall survival compared to alternative interventions?
These recommendations apply to adults with previously diagnosed glioblastoma who are suspected of experiencing progression of the neoplastic process and are amenable to surgical resection.
Level II: Repeat cytoreductive surgery is recommended in progressive glioblastoma patients to improve overall survival.
Source and rights
Published by Journal of neuro-oncology, 2022. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 2022
- Applies to
- 🇪🇺 Europe
- Scope
- Regional
- Journal
- Journal of neuro-oncology
- PubMed
- 35246769
- Added to Prognia
- 22 July 2026
More in neurology
- Recommendations for early mobilisation at Swiss Stroke Centres and Stroke Units: a practice guide and discussion paperEuropean Respiratory Society · 2026
- Clinical practice guidelines for the care of patients with a chronic subdural haematoma: multidisciplinary recommendations from presentation to recovery
